CHRM5
Basic information
Region (hg38): 15:33968497-34067458
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHRM5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 19 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 14 | 14 | ||||
Total | 0 | 0 | 33 | 1 | 2 |
Variants in CHRM5
This is a list of pathogenic ClinVar variants found in the CHRM5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-34003116-A-G | not specified | Uncertain significance (Sep 17, 2021) | ||
15-34003123-C-A | not specified | Uncertain significance (Aug 16, 2021) | ||
15-34003130-G-C | not specified | Uncertain significance (Nov 08, 2022) | ||
15-34038827-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
15-34038851-G-C | not specified | Uncertain significance (Mar 07, 2023) | ||
15-34038856-C-T | not specified | Uncertain significance (May 15, 2023) | ||
15-34038881-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
15-34038884-G-A | not specified | Uncertain significance (Jan 17, 2023) | ||
15-34038904-C-T | not specified | Uncertain significance (Apr 20, 2023) | ||
15-34038907-C-G | not specified | Uncertain significance (Aug 22, 2023) | ||
15-34038911-C-A | not specified | Uncertain significance (Jan 19, 2022) | ||
15-34038917-C-G | not specified | Uncertain significance (Mar 25, 2024) | ||
15-34038935-C-T | not specified | Uncertain significance (May 13, 2024) | ||
15-34038977-G-A | not specified | Uncertain significance (Apr 15, 2024) | ||
15-34039021-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
15-34039024-C-G | not specified | Uncertain significance (Aug 11, 2022) | ||
15-34039032-T-G | not specified | Likely benign (Mar 25, 2024) | ||
15-34039033-C-A | not specified | Uncertain significance (Dec 13, 2022) | ||
15-34062743-C-G | not specified | Uncertain significance (Jun 19, 2024) | ||
15-34062745-A-G | not specified | Uncertain significance (Feb 10, 2022) | ||
15-34062787-C-T | not specified | Uncertain significance (Dec 28, 2023) | ||
15-34062867-G-C | not specified | Uncertain significance (Apr 29, 2024) | ||
15-34062994-A-G | not specified | Uncertain significance (Aug 28, 2023) | ||
15-34063141-C-T | not specified | Uncertain significance (Feb 17, 2024) | ||
15-34063142-G-A | not specified | Uncertain significance (Aug 02, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHRM5 | protein_coding | protein_coding | ENST00000383263 | 1 | 96371 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00403 | 0.989 | 125715 | 0 | 32 | 125747 | 0.000127 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.20 | 235 | 293 | 0.802 | 0.0000158 | 3475 |
Missense in Polyphen | 83 | 134.93 | 0.61513 | 1651 | ||
Synonymous | -0.125 | 114 | 112 | 1.01 | 0.00000571 | 1088 |
Loss of Function | 2.36 | 7 | 17.7 | 0.395 | 0.00000118 | 188 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000262 | 0.000262 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000938 | 0.0000924 |
European (Non-Finnish) | 0.000106 | 0.000105 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover.;
- Pathway
- Regulation of actin cytoskeleton - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Cholinergic synapse - Homo sapiens (human);GPCRs, Class A Rhodopsin-like;Regulation of Actin Cytoskeleton;Calcium Regulation in the Cardiac Cell;Monoamine GPCRs;Signaling by GPCR;Signal Transduction;Muscarinic acetylcholine receptors;Amine ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.0829
Intolerance Scores
- loftool
- 0.586
- rvis_EVS
- 0.38
- rvis_percentile_EVS
- 75.51
Haploinsufficiency Scores
- pHI
- 0.286
- hipred
- N
- hipred_score
- 0.289
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.185
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chrm5
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; muscle phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- gastric acid secretion;G protein-coupled receptor signaling pathway;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway;G protein-coupled acetylcholine receptor signaling pathway;chemical synaptic transmission;cell population proliferation;dopamine transport;transmission of nerve impulse;regulation of phosphatidylinositol dephosphorylation;G protein-coupled serotonin receptor signaling pathway
- Cellular component
- plasma membrane;integral component of plasma membrane;cell junction;dendrite;postsynaptic membrane
- Molecular function
- phosphatidylinositol phospholipase C activity;G protein-coupled receptor activity;G protein-coupled serotonin receptor activity;G protein-coupled acetylcholine receptor activity;neurotransmitter receptor activity